Clinical Trial Update: Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating post-transplantation bendamustine and cyclophosphamide in refractory myeloid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Bendamustine (Bendamustine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Myeloid Leukemia, Acute, Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED